Drug Trial Radar · NCT06423911
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
333
Planned (sponsor's estimate)
Start
Feb 5, 2024
Primary completion
Jun 30, 2027
Study completion Jul 10, 2028
Sponsor
- Lead sponsor
- Ascentage Pharma Group Inc.Industry
- Sponsor type
- Industry
- First posted
- May 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study comparing efficacy and safety of olverembatinib (investigational arm) vs. bosutinib (control arm) in patients with CML-CP (Part A). Study will also evaluate efficacy and safety of olverembatinib (single-arm) in CML-CP patients with T315I mutation (Part B). Patients who meet ELN 2025 failure criteria while receiving bosutinib in Part A may be able to receive olverembatinib in crossover follow-on study.
Conditions
- Chronic Myeloid Leukemia
- CML
- CML, Chronic Phase
Interventions
olverembatinibDrug
olverembatinib QOD
BosutinibDrug
Bosutnib QD
Primary outcomes
What the sponsor says the trial is designed to measure.
- 24-Week MMR Rate (Part A)Time frame: 24 weeks
- 24-Week MMR Rate (Part B)Time frame: 24 weeks
Locations
163 sites in 16 countries. Site status is shown where the registry gives one.
Ascentage Investigative Site #1044
Birmingham, Alabama · Recruiting
Ascentage Investigative Site #1112
Anchorage, Alaska · Recruiting
Ascentage Investigative Site #1111
Goodyear, Arizona · Recruiting
Ascentage Investigative Site #1062
Duarte, California · Recruiting
Ascentage Investigative Site #1099
Irvine, California · Recruiting
Ascentage Investigative Site #1075
La Jolla, California · Recruiting
Ascentage Investigative Site #1100
Long Beach, California · Recruiting
Ascentage Investigative Site #1059
Los Angeles, California · Recruiting
Ascentage Investigative Site #1121
Sacramento, California · Recruiting
Ascentage Investigative Site #1109
Upland, California · Recruiting
Ascentage Investigative Site #1045
Augusta, Georgia · Recruiting
Ascentage Investigative Site #1110
Newnan, Georgia · Recruiting
Ascentage Investigative Site #1055
Chicago, Illinois · Recruiting
Ascentage Investigative Site #1095
Decatur, Illinois · Recruiting
Ascentage Investigative Site #1069
Indianapolis, Indiana · Recruiting
Ascentage Investigative Site #1065
Wichita, Kansas · Recruiting
Ascentage Investigative Site #1084
Lexington, Kentucky · Recruiting
Ascentage Investigative Site #1058
Louisville, Kentucky · Recruiting
Ascentage Investigative Site #1801
Baltimore, Maryland · Recruiting
Ascentage Investigative Site #1056
Detroit, Michigan · Recruiting
Ascentage Investigative Site #1023
Detroit, Michigan · Recruiting
Ascentage Investigative Site #1088
St Louis, Missouri · Recruiting
Ascentage Investigative Site #1097
Lincoln, Nebraska · Not yet recruiting
Ascentage Investigative Site #1066
Las Vegas, Nevada · Recruiting
Ascentage Investigative Site #1113
Reno, Nevada · Recruiting
Ascentage Investigative Site #1064
Hackensack, New Jersey · Recruiting
Ascentage Investigative Site #1054
Morristown, New Jersey · Recruiting
Ascentage Investigative Site #1098
New Brunswick, New Jersey · Recruiting
Ascentage Investigative Site #1072
Albuquerque, New Mexico · Recruiting
Ascentage Investigative Site #1068
Rochester, New York · Recruiting
Ascentage Investigative Site #1053
Shirley, New York · Recruiting
Ascentage Investigative Site #1160
Stony Brook, New York · Not yet recruiting
Ascentage Investigative Site #1019
Greenville, North Carolina · Not yet recruiting
Ascentage Investigative Site #1043
Morrisville, North Carolina · Recruiting
Ascentage Investigative Site #1173
Cleveland, Ohio · Not yet recruiting
Ascentage Investigative Site #1096
Cleveland, Ohio · Not yet recruiting
Ascentage Investigative Site #1174
Mayfield Heights, Ohio · Not yet recruiting
Ascentage Investigative Site #1139
Portland, Oregon · Not yet recruiting
Ascentage Investigative Site #1057
Philadelphia, Pennsylvania · Recruiting
Ascentage Investigative Site #1022
Pittsburgh, Pennsylvania · Recruiting
Showing 40 of 163 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.